Lumos Pharma, Inc.
LUMODelisted Dec 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001126234
Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.
Holders of 5% or more of LUMO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lumos Pharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Lumos Pharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
21 Schedule 13D and 13G filings on Lumos Pharma, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 20254:16 PM ET | Private Advisor Group, LLC | 13G/A | 0.00% | –Below 5% | Dec 31, 2024 | SEC |
| Feb 13, 20254:02 PM ET | Goldman Sachs Group Incand 1 other | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 12, 2024 | Private Advisor Group, LLC | 13GOld format | – | New | – | SEC |
| Oct 25, 202410:43 AM ET | Wells Fargo & Company | 13G/A | 0.80%65.0K shares | –Below 5% | Sep 30, 2024 | SEC |
| Feb 9, 2024 | Goldman Sachs Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2024 | Wells Fargo & Company | 13GOld format | – | New | – | SEC |
| Nov 29, 2023 | Blackstone Holdings II L.P. | 13D/AOld format | – | – | – | SEC |
| Jun 20, 2023 | Farb Daniel Stuart | 13D/AOld format | – | – | – | SEC |
| Jun 2, 2023 | Farb Daniel Stuart | 13D/AOld format | – | – | – | SEC |
| May 25, 2023 | Farb Daniel Stuart | 13D/AOld format | – | – | – | SEC |
| Feb 15, 2023 | Farb Daniel Stuart | 13DOld format | – | – | – | SEC |
| Feb 7, 2023 | Goldman Sachs Group Inc | 13GOld format | – | New | – | SEC |
| Jan 24, 2023 | Farb Daniel Stuart | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2022 | Farb Daniel Stuart | 13G/AOld format | – | – | – | SEC |
| Feb 1, 2022 | Farb Daniel Stuart | 13GOld format | – | New | – | SEC |
| Jan 5, 2022 | New Enterprise Associates 14, L.P. | 13D/AOld format | – | – | – | SEC |
| Aug 30, 2021 | SHV Management Services II, LP | 13DOld format | – | New | – | SEC |
| May 26, 2021 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Lion Point Capital, LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Lumos Pharma, Inc. shares.
No Form 144 notices for Lumos Pharma, Inc. are on file.